Luke L Lairson

This inventor holds 12 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Scripps Research Institute, California Institute of Technology, Novartis Ag. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luke L Lairson. Retrieved from https://idiyas.com/inventor/luke-l-lairson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

La Jolla, CA (US) (2017)
San Diego, CA (US) (2017 - 2024)

Company Filing History:

12 out of 1,208

Scripps Research Institute

patents

2 out of 4,626

California Institute of Technology

The University of Texas System

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12263165 - Small molecule inhibitors of cancer stem cells and mesenchymal cancer types (2025-04-01),

2. 11998602 - Methods for promoting myelination and for treating demyelinating diseases (2024-06-04),

3. 11759461 - Small molecule inhibitors of cancer stem cells and mesenchymal cancer types (2023-09-19),

4. 11701364 - Agonists of stimulator of interferon genes sting (2023-07-18),

5. 11246873 - Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate (2022-02-15),

6. 10660899 - Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate (2020-05-26),

7. 10494365 - Small molecule inhibitor of 3-phosphoglycerate dehydrogenase and uses thereof (2019-12-03),

8. 10493080 - Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate (2019-12-03),

9. 10336735 - Small molecule inhibitors of fibrosis (2019-07-02),

10. 9981956 - Small molecule inhibitors of fibrosis (2018-05-29),

11. 9663499 - Small molecule inhibitors of fibrosis (2017-05-30),

12. 9592288 - Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate (2017-03-14),

Title: The Inventive Journey of Luke L Lairson

Introduction: Luke L Lairson is a prolific inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Luke L Lairson holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Luke L Lairson has worked with top research institutions and companies to bring his inventions to life, revolutionizing industries along the way.

Collaborations: Throughout his career, Luke L Lairson has collaborated with leading universities, tech companies, and research institutions, demonstrating his ability to work across disciplines to drive innovation.

Conclusion: Luke L Lairson's passion for innovation and his relentless drive to push boundaries have solidified his reputation as a visionary inventor in the vibrant city of San Diego, CA.

Profile summary based on public USPTO records.